Vista Current Coverage

Vista Partners Discontinues Coverage on Immune Pharmaceuticals (IMNP)

View Disclaimer

Vista Partners discontinued coverage on Immune Pharmaceuticals (IMNP) on September 20, 2016 at the closing price of $.29 and may seek to resume coverage at a later date.